Enanta Pharmaceuticals
ENTA
#8491
Rank
C$0.40 B
Marketcap
C$13.79
Share price
-9.61%
Change (1 day)
-23.28%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Cash on Hand

Cash on Hand as of June 2026 : C$0.27 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has C$0.27 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Enanta Pharmaceuticals - Cash on Hand chart (from 2011 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-09-30C$0.26 B-21.67%
2024-09-30C$0.33 B-33.22%
2023-09-30C$0.50 B46.39%
2022-09-30C$0.34 B10.96%
2021-09-30C$0.30 B-39.84%
2020-09-30C$0.51 B15.89%
2019-09-30C$0.44 B11.98%
2018-09-30C$0.39 B42.88%
2017-09-30C$0.27 B0.34%
2016-09-30C$0.27 B43.01%
2015-09-30C$0.19 B90.12%
2014-09-30C$0.10 B-2.92%
2013-09-30C$0.10 B143.24%
2012-09-30C$43.07 M78.11%
2011-09-30C$24.18 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
C$24.62 B 8,991.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$12.82 B 4,636.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$9.38 B 3,366.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$11.22 B 4,043.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.20 B 3,668.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$17.98 B 6,538.84%๐Ÿ‡บ๐Ÿ‡ธ USA